A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients

NCT05454397 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-07-12

No results posted yet for this study

Summary

Stroke is the leading cause of premature death and disability, and early recognition and treatment of dysphagia is fundamental to stroke management. Early and full tube feeding in the acute phase of stroke helps to address nutritional problems resulting from dysphagia and impaired consciousness and helps to reduce morbidity and mortality and poor outcomes. Current guidelines for acute stroke management do not address the goal of tube feeding of enteral nutrition for energy and protein. In the treatment of acute stroke, there is a strong global focus on pharmacological thrombolysis or mechanical thrombolysis, with nutritional interventions being a less explored topic. Real-world evidence on large samples, feeding attainment and outcomes, and nutrition in the acute phase of stroke is lacking in China . The aim of this study was to understand the current status of nutritional therapy in stroke hospitalization in neurology and its impact on prognosis nationwide, and to improve the standardized management process of enteral nutrition therapy in the acute phase of stroke.

Conditions

  • Acute Stroke

Interventions

OTHER

Observational study, no intervention

Observational study, no intervention

Sponsors & Collaborators

  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • Yantai Yuhuangding Hospital

    collaborator OTHER
  • The First Hospital of Jilin University

    collaborator OTHER
  • Qilu Hospital of Shandong University

    collaborator OTHER
  • ZHEJIANG PROVINCE XIAOSHAN HOSPITAL

    collaborator UNKNOWN
  • Affiliated Wenling Hospital of Wenzhou Medical University

    collaborator OTHER
  • Ganzhou People's Hospital

    collaborator UNKNOWN
  • Affiliated Hospital of Jining Medical hospital

    collaborator UNKNOWN
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Zhongda Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • The First People's Hospital of Kunshan

    collaborator OTHER
  • The 2nd Affiliated Hospital of Wenzhou Medical University

    collaborator UNKNOWN
  • THE FIRST PEOPLE'S HOSPITAL OF JIASHAN

    collaborator UNKNOWN
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Fujian Province Zhangzhou Hospital

    collaborator UNKNOWN
  • People's Hospital of Chongqing

    collaborator OTHER
  • Nanjing Zijin Hospital

    collaborator UNKNOWN
  • Red Cross Hospital, Hangzhou, China

    collaborator OTHER
  • Wenzhou Hospital of Chinese Medicine

    collaborator UNKNOWN
  • Kaifeng Central Hospital

    collaborator OTHER
  • First Affiliated Hospital of Guangxi Medical University

    collaborator OTHER
  • Zhongshan Hospital of Xiamen University

    collaborator UNKNOWN
  • Xi'an Encephalopathy of Traditional Chinese Medicine Hospital

    collaborator UNKNOWN
  • 903 Hospital of Chinese People's Liberation Army

    collaborator OTHER
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • Second Affiliated Hospital of Suzhou University

    collaborator OTHER
  • Tongji Hospital

    collaborator OTHER
  • The Affiliated Hospital o fQingdao University

    collaborator UNKNOWN
  • The First Affiliated Hospital of Anhui Medical University

    collaborator OTHER
  • Yancheng Third People's Hospital

    collaborator UNKNOWN
  • Linyi People's Hospital

    collaborator OTHER
  • Dongfang Hospital of Beijing University of Chinese Medicine

    collaborator UNKNOWN
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • Suyue Pan, M.D., Ph.D. · Department of Neurology, Nanfang Hospital, Southern Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2022-10-15
Completion
2023-10-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05454397 on ClinicalTrials.gov